All Cardiometabolic disease articles
-
NewsSwitching refined sugar for maple sugar alters gut microbiota
A new study has found that substituting two tablespoons of pure maple syrup for refined sugars reduced several cardiometabolic risk factors in humans.
-
NewsGut microbiome has central role in human aging
The gut microbiome holds a central role in human aging, influencing everything from metabolic function to immune health, a new review shows.
-
NewsEarly life exposure to common chemical permanently disrupts gut microbiome
A study in mice finds that by significantly disrupting the gut microbiome, early life exposure to persistent organic pollutants influenced the development of metabolic disorder in adult mice.
-
NewsIncidence of heart attacks and strokes found to be lower after COVID-19 vaccination
A new study involving nearly the whole adult population of England has found that the incidence of heart attacks and strokes was lower after COVID-19 vaccination than before or without vaccination.
-
NewsExploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial
Current or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse cardiovascular events (MACE) in people with HIV, according to an exploratory analysis from a large international clinical trial primarily funded by the National Institutes of Health (NIH). There ...
-
NewsResearchers develop new way for beneficial microbes to survive extreme conditions and space exploration
The team’s formulations allow microbial therapeutics to maintain their potency and function over time despite extreme temperatures, harsh manufacturing processes, and radiation exposure.
-
NewsStudy links gut microbiome changes to increased risk of type 2 diabetes
Researchers have found that specific species and strains of bacteria are linked to changes in the functioning of the gut microbiome and a person’s risk of type 2 diabetes.
-
NewsMetformin and AGIs show potential for improved outcomes in COVID-19 patients with type 2 diabetes
A new study has found a significant association between metformin and AGI use and reduced all-cause mortality in COVID-19 patients with Type 2 diabetes. Conversely, insulin use was linked to an increased risk of death.
-
NewsNew approach to measuring ‘healthy microbiomes’ in nature and the gut
Focusing on four common diseases – diabetes, heart disease, depression and bowel cancer – new research provides insights into the importance of a healthy microbiome balance in the human gut and in the environment.
-
NewsSARS-CoV-2 and type 1 diabetes in children: new study aims to explore the relationship
A new study will investigate whether vaccination against SARS-CoV-2 in the first year of life can protect children who have an increased genetic risk for type 1 diabetes from developing the condition.
-
NewsCranberry extracts could boost microbiota and counter cardiometabolic diseases
Cranberry extracts appear to improve intestinal microbiota and help prevent chronic diseases such as diabetes and cardiovascular diseases, according to a study that reported beneficial effects after only four days of use.
-
NewsCelebrity weight-loss drug helps people with HIV fight fatty liver, study shows
Scientists have found that a medication used to treat diabetes and obesity – and touted on social media for weight loss – can be a powerful weapon against a type of fatty liver disease in people with HIV.
-
NewsNonalcoholic fatty liver disease: changes in gut microbiota and blood lipids
This study aimed to explore differences in the gut microbial community and blood lipids between normal livers and those affected by NAFLD using 16S ribosomal deoxyribonucleic acid sequencing.
-
NewsGut microbiota acts like an auxiliary liver
Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study.
-
NewsLink revealed between the gut microbiome and aortic aneurysm
This study used Mendelian randomization (MR) to gain new insights into the relationship between the gut microbiota and aortic aneurysm.
-
NewsResearchers show viral infections pose early heart risks
Myocarditis is often triggered by the body’s immune response to a viral infection, but a new study shows that the virus itself creates potentially dangerous conditions in the heart before inflammation sets in.
